PE20011188A1 - El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos - Google Patents

El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos

Info

Publication number
PE20011188A1
PE20011188A1 PE2001000364A PE2001000364A PE20011188A1 PE 20011188 A1 PE20011188 A1 PE 20011188A1 PE 2001000364 A PE2001000364 A PE 2001000364A PE 2001000364 A PE2001000364 A PE 2001000364A PE 20011188 A1 PE20011188 A1 PE 20011188A1
Authority
PE
Peru
Prior art keywords
bacterial
composition
azalides
antibiotics
mammals
Prior art date
Application number
PE2001000364A
Other languages
English (en)
Inventor
Peter Connor Canning
Wayne Alan Boettner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20011188A1 publication Critical patent/PE20011188A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: a) COMPUESTOS AZALIDOS DE FORMULA I Y II DONDE R ES H, ALQUILO C1-C10, CICLOALQUILO C3-C7, DONDE AMBOS GRUPOS R SON IDENTICOS Y b) UN VEHICULO FARMACEUTICAMENTE ACEPTABLE TAL COMO: i) AGUA; ii) ACIDOS EN UNA CONCENTRACION TOTAL DE 0,2 mmol A 1,0 mmol POR ml DE LA MEZCLA TAL COMO ACIDO ACETICO, ACIDO BENCENO SULFONICO, ACIDO CITRICO ENTRE OTROS; iii) CODISOLVENTES MISCIBLES CON AGUA EN UNA CANTIDAD DE 250mg A 750mg POR ml DE LA COMPOSICION TAL COMO ETANOL, ISOPROPANOL, PROPILENGLICOL, ENTRE OTROS; iv) DE 0,01mg A 10mg/ml DE ANTIOXIDANTE TAL COMO BISULFITO DE SODIO, SULFITO DE SODIO, TIOSULFATO DE SODIO, MONOTIOGLICEROL, ENTRE OTROS; v) DE 0,01mg A 10 mg/ml DE UN CONSERVANTE TAL COMO CLORURO DE BENZALCONIO, CLORURO DE BENZETONIO, FENOL, ENTRE OTROS. LA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS O PROTOZOARIA
PE2001000364A 2000-04-27 2001-04-24 El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos PE20011188A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19996100P 2000-04-27 2000-04-27

Publications (1)

Publication Number Publication Date
PE20011188A1 true PE20011188A1 (es) 2001-11-24

Family

ID=22739732

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000364A PE20011188A1 (es) 2000-04-27 2001-04-24 El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos

Country Status (30)

Country Link
US (2) US20020019353A1 (es)
EP (1) EP1276747A1 (es)
JP (1) JP2004516233A (es)
KR (1) KR20030031479A (es)
CN (1) CN1227258C (es)
AP (1) AP2002002652A0 (es)
AR (1) AR028041A1 (es)
AU (1) AU4269301A (es)
BG (1) BG107168A (es)
BR (1) BR0110382A (es)
CA (1) CA2407448A1 (es)
CZ (1) CZ20023409A3 (es)
EA (1) EA200200995A1 (es)
GT (1) GT200100063A (es)
HU (1) HUP0300585A3 (es)
IL (1) IL152421A0 (es)
IS (1) IS6559A (es)
MA (1) MA26896A1 (es)
MX (1) MXPA02010586A (es)
NO (1) NO20025134L (es)
OA (1) OA12257A (es)
PA (1) PA8515601A1 (es)
PE (1) PE20011188A1 (es)
PL (1) PL359861A1 (es)
SK (1) SK14882002A3 (es)
TN (1) TNSN01063A1 (es)
UY (1) UY26678A1 (es)
WO (1) WO2001081358A1 (es)
YU (1) YU78702A (es)
ZA (1) ZA200208603B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
WO2003011266A2 (en) * 2001-08-01 2003-02-13 Pfizer Products Inc. Azalide antibiotic compositions
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
WO2009117036A2 (en) * 2007-12-21 2009-09-24 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
JP6441794B2 (ja) * 2012-06-27 2018-12-19 ケミン、インダストリーズ、インコーポレーテッドKemin Industries, Inc. 抗コクシジウム活性を有する植物部分および抽出物
US10568923B2 (en) * 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
JP2020513730A (ja) 2016-12-15 2020-05-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー コンパニオンアニマルにおける細菌を調節する組成物及び方法
CN106749458A (zh) * 2017-02-21 2017-05-31 西南大学 苹果酸替米考星复盐的制备方法
CN106905396A (zh) * 2017-02-21 2017-06-30 西南大学 富马酸替米考星复盐的制备方法
CN106905395A (zh) * 2017-02-21 2017-06-30 西南大学 丁二酸替米考星复盐的制备方法
US11059845B2 (en) * 2017-02-22 2021-07-13 ISR Immune System Regulation Holding AB (publ) Immune stimulating macrolides
SG11202105227QA (en) * 2018-11-19 2021-06-29 Zikani Therapeutics Inc C10-alkylene substituted 13-membered macrolides and uses thereof
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法
WO2023038852A1 (en) * 2021-09-07 2023-03-16 Zoetis Services Llc Immunomodulating azalides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
NO20025134D0 (no) 2002-10-25
US20040235759A1 (en) 2004-11-25
AU4269301A (en) 2001-11-07
SK14882002A3 (en) 2004-11-03
JP2004516233A (ja) 2004-06-03
GT200100063A (es) 2002-02-18
IL152421A0 (en) 2003-05-29
WO2001081358A1 (en) 2001-11-01
EP1276747A1 (en) 2003-01-22
NO20025134L (no) 2002-12-19
ZA200208603B (en) 2003-10-24
CN1227258C (zh) 2005-11-16
UY26678A1 (es) 2001-12-28
AR028041A1 (es) 2003-04-23
CA2407448A1 (en) 2001-11-01
US20020019353A1 (en) 2002-02-14
KR20030031479A (ko) 2003-04-21
CZ20023409A3 (cs) 2004-01-14
EA200200995A1 (ru) 2003-04-24
HUP0300585A3 (en) 2003-09-29
BR0110382A (pt) 2003-06-24
MA26896A1 (fr) 2004-12-20
TNSN01063A1 (fr) 2005-11-10
BG107168A (bg) 2003-07-31
PL359861A1 (en) 2004-09-06
YU78702A (sh) 2005-11-28
IS6559A (is) 2002-09-20
HUP0300585A2 (hu) 2003-06-28
OA12257A (en) 2003-11-06
AP2002002652A0 (en) 2002-12-31
MXPA02010586A (es) 2003-03-10
PA8515601A1 (es) 2002-07-30
CN1429232A (zh) 2003-07-09

Similar Documents

Publication Publication Date Title
PE20011188A1 (es) El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
PE20011050A1 (es) Compuestos antibioticos de azalida
UY25330A1 (es) Nuevos macrólidos
ATE318598T1 (de) Antioxidierende stabilisierungssysteme für pharmazeutische formulierungen
AR030093A1 (es) Sistema para la distribucion topica del gel
GT199800207A (es) Nuevos derivados de la eritromicina.
MXPA02012611A (es) Composicion anestesica, acuosa, clara.
EA200500804A1 (ru) Топические противоинфекционные композиции
BR9812148A (pt) Derivados de eritromicina 6,9-ligados em ponte
BG104340A (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
PA8485601A1 (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
BR9813317A (pt) Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto
BG104434A (en) 2-halo-6-o-substituted ketolide derivatives
CO5050328A1 (es) Sistema solvente para la mejor penetracion de compuestos farmaceuticos
DK1212039T3 (da) Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
BR9708929A (pt) Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
AR031010A1 (es) Una composicion farmaceutica, util para inhibir el dano celular
WO1999011651A3 (en) 3-descladinose 6-o-substituded erythromycin derivatives
MXPA01007705A (es) Derivado de benzamida y medicamento que lo contiene.
WO2006059221A3 (en) Topical hydro-alcoholic formulations of oxazolidinone antibacterial agents
PE20030092A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio
PE13395A1 (es) Composicion farmaceutica de imidazolil carbazolona
RU95107147A (ru) Производные циклогексанкарбоновой кислоты, смесь их изомеров или отдельные изомеры и физиологически переносимые соли и фармацевтическая композиция с тормозящей ферментный комплекс глюкоза-6-фосфатазы печени активностью

Legal Events

Date Code Title Description
FD Application declared void or lapsed